ORCHARD THERAPEUTICS PLC Selling, General and Administrative Expense
ORCHARD THERAPEUTICS PLC reported Selling, General and Administrative Expense of $11.61 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC selling, general and administrative expense for the quarter ending 2023-09-30 was $11.61M, a 0.98% increase year-over-year.
- ORCHARD THERAPEUTICS PLC selling, general and administrative expense for the quarter ending 2023-06-30 was $10.99M, a 19.94% decline year-over-year.
- ORCHARD THERAPEUTICS PLC selling, general and administrative expense for the quarter ending 2023-03-31 was $11.13M, a 16.27% decline year-over-year.
- ORCHARD THERAPEUTICS PLC selling, general and administrative expense for the quarter ending 2022-12-31 was $10.60M, a 21.78% decline year-over-year.
- ORCHARD THERAPEUTICS PLC selling, general and administrative expense for fiscal 2022 was $49.13M, a 10.53% decline from fiscal 2021.
- ORCHARD THERAPEUTICS PLC selling, general and administrative expense for fiscal 2021 was $54.91M, a 15.51% decline from fiscal 2020.
- ORCHARD THERAPEUTICS PLC selling, general and administrative expense for fiscal 2020 was $64.99M, a 13.58% increase from fiscal 2019.
- ORCHARD THERAPEUTICS PLC selling, general and administrative expense for fiscal 2019 was $57.22M, a 82.42% increase from fiscal 2018.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $11.61M 10-Q · filed 2023-11-13 | $22.60M derived: sum of 2 quarters · filed 2023-11-13 | $33.74M 10-Q · filed 2023-11-13 | $44.34M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $10.99M 10-Q · filed 2023-08-10 | $22.13M 10-Q · filed 2023-08-10 | $32.73M derived: sum of 3 quarters · filed 2023-08-10 | $44.22M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $11.13M 10-Q · filed 2023-05-15 | $21.73M derived: sum of 2 quarters · filed 2023-05-15 | $33.23M derived: sum of 3 quarters · filed 2023-11-13 | $46.96M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $22.10M derived: sum of 2 quarters · filed 2023-11-13 | $35.83M derived: sum of 3 quarters · filed 2023-11-13 | $49.13M 10-K · filed 2023-03-14 |
| 2022-09-30 | $11.50M 10-Q · filed 2023-11-13 | $25.23M derived: sum of 2 quarters · filed 2023-11-13 | $38.52M 10-Q · filed 2023-11-13 | $52.08M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $13.73M 10-Q · filed 2023-08-10 | $27.03M 10-Q · filed 2023-08-10 | $40.58M derived: sum of 3 quarters · filed 2023-08-10 | $53.62M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $13.30M 10-Q · filed 2023-05-15 | $26.85M derived: sum of 2 quarters · filed 2023-05-15 | $39.89M derived: sum of 3 quarters · filed 2023-05-15 | $54.15M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $13.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $26.59M derived: sum of 2 quarters · filed 2023-03-14 | $40.85M derived: sum of 3 quarters · filed 2023-03-14 | $54.91M 10-K · filed 2023-03-14 |
| 2021-09-30 | $13.04M 10-Q · filed 2022-11-14 | $27.30M derived: sum of 2 quarters · filed 2022-11-14 | $41.35M 10-Q · filed 2022-11-14 | $57.58M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $14.26M 10-Q · filed 2022-08-04 | $28.31M 10-Q · filed 2022-08-04 | $44.54M derived: sum of 3 quarters · filed 2022-08-04 | $57.50M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $14.05M 10-Q · filed 2022-05-12 | $30.28M derived: sum of 2 quarters · filed 2022-05-12 | $43.23M derived: sum of 3 quarters · filed 2022-05-12 | $58.89M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $16.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $29.18M derived: sum of 2 quarters · filed 2022-03-30 | $44.84M derived: sum of 3 quarters · filed 2022-03-30 | $64.99M 10-K · filed 2022-03-30 |
| 2020-09-30 | $12.96M 10-Q · filed 2021-11-04 | $28.61M derived: sum of 2 quarters · filed 2021-11-04 | $48.76M 10-Q · filed 2021-11-04 | $67.29M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $15.66M 10-Q · filed 2021-08-04 | $35.80M 10-Q · filed 2021-08-04 | $54.34M derived: sum of 3 quarters · filed 2021-08-04 | $68.56M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $20.14M 10-Q · filed 2021-05-13 | $38.68M derived: sum of 2 quarters · filed 2021-05-13 | $52.90M derived: sum of 3 quarters · filed 2021-05-13 | $66.57M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $18.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $32.75M derived: sum of 2 quarters · filed 2021-03-02 | $46.43M derived: sum of 3 quarters · filed 2021-03-02 | $57.22M 10-K · filed 2021-03-02 |
| 2019-09-30 | $14.22M 10-Q · filed 2020-11-03 | $27.90M derived: sum of 2 quarters · filed 2020-11-03 | $38.69M 10-Q · filed 2020-11-03 | $50.64M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | $13.67M 10-Q · filed 2020-08-06 | $24.46M 10-Q · filed 2020-08-06 | $36.42M derived: sum of 3 quarters · filed 2020-08-06 | $43.88M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $10.79M 10-Q · filed 2020-05-07 | $22.74M derived: sum of 2 quarters · filed 2020-05-07 | $30.21M derived: sum of 3 quarters · filed 2020-05-07 | $37.63M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $11.95M derived: 10-K 12 month − 6-K 9 month · filed 2020-02-27 | $19.42M derived: sum of 2 quarters · filed 2020-02-27 | $26.84M derived: sum of 3 quarters · filed 2020-02-27 | $31.37M 10-K · filed 2020-02-27 |
| 2018-09-30 | $7.47M 6-K · filed 2019-11-07 | $14.89M derived: sum of 2 quarters · filed 2019-11-07 | $19.41M 6-K · filed 2019-11-07 | |
| 2018-06-30 | $7.42M 6-K · filed 2019-08-08 | $11.95M 6-K · filed 2019-08-08 | ||
| 2018-03-31 | $4.53M 6-K · filed 2019-05-28 | |||
| 2017-12-31 | $5.99M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $3.00M 20-F · filed 2019-03-22 |